About Haemophilia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

22 febbraio 2021 17:11
Fonte: Adnkronos
#chimica-e-farmacia
- LACHEN, Switzerland, Feb. 22, 2021 /PRNewswire/ Octapharma announced today that the final results from the NuProtect study on the immunogenicity of Nuwiq® in previously untreated patients (PUPs) with severe haemophilia A have been published in the leading medical journal Thrombosis and Haemostasis (Liesner RJ et al. Simoctocog Alfa (Nuwiq®) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0040-1722623). 
The NuProtect study (NCT01712438; EudraCT 2012-002554-23) was a prospective, multinational, open-label, non-controlled phase III study initiated in March 2013 to assess the immunogenicity, efficacy and safety of Nuwiq®. The study recruited patients of any age and ethnicity at 38 sites in 17 countries and followed patients for 100 exposure days or up to 5 years. With enrolment of 1 ....

United States , Switzerland General , United Kingdom , City Of , Nordrhein Westfalen , Larisa Belyanskaya , Prnewswire Octapharma , Anthony Chan , Olaf Walter , Professor Of Paediatrics At Mcmaster University , Previously Untreated Patients , Severe Haemophilia , Final Results , Great Ormond Street Hospital , Board Member , Mcmaster University , Adv Hematol , About Haemophilia , About Octapharma Headquartered , ஒன்றுபட்டது மாநிலங்களில் , சுவிட்சர்லாந்து ஜநரல் , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , னோற்ர்ேன் வெஸ்ட்ஃபாலன் , அந்தோணி சான் , ஓலேஃப் வால்டர் ,